Insect Antimicrobial Peptide Cecropin A Modulates Chicken Gut Immunity and Strengthens Barrier Integrity

Cecropin A (an insect-derived antimicrobial peptide) showed immunomodulatory effects in chicken ileal explant cultures without cytotoxicity. At the higher dose (6.25 µg/mL), it increased IL-2 production (an immune activation signal) and elevated claudin-3 expression (a tight junction protein that strengthens the gut barrier). Under inflammatory conditions (Poly I:C challenge), the lower dose of cecropin A (3.125 µg/mL) reduced IL-6 (an inflammatory cytokine). Cell viability remained unaffected at both doses.

Ex vivo chicken ileal explant cultures treated with cecropin A at two concentrations (3.125 and 6.25 µg/mL) with or without Poly I:C (a synthetic inflammatory stimulus). Endpoints: cell viability (metabolic activity, LDH release), cytokine production (IL-2, IL-6), and tight junction protein expression (claudin-3). This ex vivo approach preserves the tissue architecture of the gut while allowing controlled peptide exposure.

Antibiotic resistance is a growing crisis in livestock farming, where antibiotics have long been used to promote growth and prevent disease. Antimicrobial peptides like cecropin A could serve as alternatives — this study shows cecropin A can modulate the chicken immune system, reduce inflammation, and strengthen the gut barrier without killing cells. If effective in live animals, peptide-based feed additives could reduce antibiotic use in poultry farming.

Cecropins were among the first antimicrobial peptides ever discovered (in the cecropia moth in the 1980s). This study extends their potential from direct antimicrobial killing to immunomodulation and gut barrier support — a broader range of benefits relevant to livestock health. The poultry industry is one of the largest consumers of antibiotics globally, and regulatory pressure to reduce antibiotic use is intensifying. Peptide-based feed additives represent one of several alternative approaches, alongside probiotics, phytogenics, and organic acids.

This is an ex vivo study using tissue explants, not live chickens. The artificial inflammatory stimulus (Poly I:C) doesn't perfectly replicate natural pathogen exposure. Only two concentrations were tested. Long-term effects and whether cecropin A survives passage through the chicken digestive system when given orally are unknown. Results in poultry may not translate to other species.